S‐222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S‐222611 (25 mg/kg)Hidekazu Tanaka,Michinari Hirata,Satomi Shinonome,Toru Wada,Motofumi Iguchi,Keiji Dohi,Makiko Inoue,Yukichi Ishioka,Kanji Hojo,Tomomi Yamada,Tatsuya Sugimoto,Koichi Masuno,Kenichi Nezasa,Norihito Sato,Kenji Matsuo,Shuji Yonezawa,Eugene P Frenkel,Michitaka ShichijoCancer Science（2014）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
